Autolus Therapeutics plc Cash Flow Statement

Cash Flow Statement Sep2016 Sep2017 Sep2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -12.55M-19.68M-44.73M-123.81M-142.06M-142.14M-148.87M-208.38M-220.66M
Depreciation and Depletion 0.48M1.01M1.71M4.60M5.70M8.60M7.30M6.60M7.60M
Share-based Compensation 2.26M3.15M6.76M30.21M20.11M9.94M12.01M11.20M15.47M
Deferred Taxes -0.40M-1.34M0.07M0.27M0.99M0.18M
Gains from Investment Securities -0.01M0.70M26.96M-0.67M9.79M41.15M2.39M
Asset Writedowns and Impairment 4.10M0.40M0.41M
Non-cash Items 0.01M
Cash from Operations -9.85M-16.36M-31.54M-117.76M-117.86M-112.31M-145.59M-206.27M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.20M
Depreciation & Amortization (CF) 0.48M1.01M1.71M4.61M5.66M8.46M7.42M6.57M7.55M
Change in Working Capital
Change in Inventory 4.23M
Change in Account Payables 0.51M0.43M0.84M-1.45M1.44M-1.82M0.02M-0.51M1.59M
Change in Accured Expenses 0.31M1.09M11.03M21.40M27.78M23.67M40.80M
Change in Taxes 21.62M25.03M20.04M
Investing Activities
Capital Expenditures 1.85M2.88M9.12M18.34M14.68M8.86M10.84M10.99M22.07M
Change in Intangibles 0.41M0.33M12.74M
Cash from Investing Activities -1.85M-2.88M-9.53M-18.67M-14.68M-8.86M-10.84M-10.99M-394.55M
Financing Activities
Other financing activities 0.12M0.81M7.10M5.80M11.45M10.36M0.91M29.36M
Change in Capital Stock
Shares Issued 32.22M127.69M156.92M115.92M79.75M245.90M163.85M0.03M549.98M
Misc.
Cash from Financing Activities 32.22M127.69M156.92M108.86M74.42M284.06M223.61M-0.88M589.55M
Exchange Rate Effect -2.66M0.56M-5.83M5.16M0.68M-0.75M-28.38M15.03M-0.26M
Change in Cash 17.86M109.01M110.02M-6.12M-57.34M156.59M72.08M-142.43M-11.53M
Beginning Cash Balance 10.20M28.06M136.97M216.77M210.64M153.75M310.35M381.99M238.91M
Free Cash Flow -11.70M-19.24M-40.66M-18.34M-132.44M-126.72M-123.15M-156.57M-228.35M
Net Cash Flow 20.52M108.45M115.85M90.19M-58.02M157.34M100.46M-157.46M-11.27M